Ipsen’s IPN10200 shows promising results in Phase II aesthetics trial
PositiveFinancial Markets

Ipsen's recent Phase II trial for IPN10200 has shown promising results in the aesthetics field, indicating potential advancements in cosmetic treatments. This is significant as it could lead to new options for patients seeking aesthetic improvements, enhancing their quality of life and boosting Ipsen's position in the competitive market.
— Curated by the World Pulse Now AI Editorial System